Literature DB >> 2369429

Eosinophilia-myalgia syndrome due to L-tryptophan ingestion. Report of four cases and review of the Maryland experience.

R Roubenoff1, T Coté, R Watson, M L Levin, M C Hochberg.   

Abstract

Eosinophilia-myalgia syndrome (EMS) is a recently described clinical entity that has been ascribed to taking over-the-counter preparations of the amino acid L-tryptophan. We describe 4 patients with EMS, 3 of whom presented with eosinophilic fasciitis, and we review the epidemiology of EMS reported in Maryland and discuss the possible pathophysiology of the disease. EMS should be considered in the differential diagnosis of severe myalgia, eosinophilia, and eosinophilic fasciitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2369429     DOI: 10.1002/art.1780330703

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

1.  An unusual soft tissue tumour and peripheral eosinophilia.

Authors:  B Banerjee; M Nashi; G R Dixon
Journal:  Postgrad Med J       Date:  1998-07       Impact factor: 2.401

Review 2.  Tryptophan. Current status and future trends for oral administration.

Authors:  L D Kaufman; R M Philen
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

3.  A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome.

Authors:  R Klein; P A Berg
Journal:  Clin Investig       Date:  1994-07

Review 4.  Effector T cell plasticity: flexibility in the face of changing circumstances.

Authors:  Kenneth M Murphy; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.